Overactive Bladder Treatment Market Expected to Reach $3.5 Billion by 2031

Overactive bladder treatment market size was valued at $2.4 billion in 2021, and is estimated to reach $3.5 billion by 2031, growing at a CAGR of 3.6% from 2022 to 2031. The overactive bladder treatment market trends that drive the growth of the market include an increase in incidences of overactive bladder. For instance, according to Hartford HealthCare, a Tallwood Urology and Kidney Institute, overactive bladder affects about 33 million American men and women every year. This number is expected to be greater as people living with overactive bladder do not seek help as it seems to be embarrassing. Overactive bladder is mainly caused due to factors such as involuntary contraction of the bladder muscles, neurological disorders such as stroke and multiple sclerosis, diabetes, urinary tract infections, abnormalities in the bladder such as tumors or bladder stones and others. Thus, rise in incidences of overactive bladder in population around the globe increases the demand for overactive bladder treatment medications, which propels the growth of overactive bladder treatment market size.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
Pfizer Inc., Teva Pharmaceutical Industries Limited, Alembic Pharmaceuticals Limited, Sumitomo Pharma Co., Ltd, Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Astellas Pharma Inc., Lupin, AbbVie Inc., Cipla Ltd

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/10908

The anticholinergics segment is anticipated to grow at a fastest rate during the forecast period, owing to the increase in incidences of overactive bladder, increase in awareness among the population regarding urological conditions such as overactive bladder and others. On the basis of disease type, the market is classified into idiopathic overactive bladder and neurogenic overactive bladder. The idiopathic overactive bladder segment dominated the market in 2021, which was attributed to increased incidences of idiopathic overactive bladder and rise in awareness among people about the condition and treatment options. On the other hand, the neurogenic overactive bladder segment is anticipated to grow at the highest rate during the forecast period, owing to technological advances in the treatment of OAB.

On the basis of distribution channel, the market is segmented into hospital pharmacies, online providers and drug stores and retail pharmacies. The drug stores and retail pharmacies exhibited the highest growth in 2021, owing to the increase in number of drug stores and pharmacies around the globe, and due to easy availability of OAB medications in the drug store. On the other hand, the online providers segment is anticipated to grow at the fastest rate owing to easy accessibility of medications and doors step delivery services. In addition, the pandemic has created many shifts in consumer behavior, and one of the most impactful changes is the buying drugs from e-commerce websites, which is also anticipated to boost the segment growth.

Region wise, North America obtained the highest overactive bladder treatment market share in 2021, owing to the rise in incidences of overactive bladder condition due to increase in prevalence of conditions such as diabetes, kidney disorders, neurological disorders and others. On the other hand, Asia-Pacific is expected to witness highest growth during the forecast period, owing to factors such as rise in investments in manufacturing of high-quality products by major key players, and availability of raw materials for manufacturing of overactive bladder treatment medications.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/10908

𝐎𝐮𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐏𝐫𝐨𝐯𝐢𝐝𝐞𝐬 𝐘𝐨𝐮 𝐀𝐧𝐬𝐰𝐞𝐫 𝐭𝐨 𝐁𝐞𝐥𝐨𝐰 𝐌𝐞𝐧𝐭𝐢𝐨𝐧𝐞𝐝 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2023?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.